Trial intelligence / Profile preview

Silybum marianum for treatment of tinnitus

IRCT20160813029327N13Phase 3Completed

Sponsor
Islamic Azad University
Start
May 2018
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of silybum marianum extract in tinnitus, sponsored by Islamic Azad University. Started May 2018; status: completed.

02

Drugs

silybum marianum extract
03

Conditions

tinnitus

Beyond the preview

Go deeper on IRCT20160813029327N13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20160813029327N13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call